Last updated on September 2020

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Brief description of study

Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis

Detailed Study Description

Assess the safety and efficacy of nemolizumab in subjects with moderate-to-severe AD

Clinical Study Identifier: NCT03989349

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.